News for 'Dr Reddys'

US drug shortage, stable pricing set to boost pharma revenues

US drug shortage, stable pricing set to boost pharma revenues

Rediff.com24 Jul 2023

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India's pharmaceutical companies during the first quarter of this financial year, analysts said. Most brokerages estimate a top line growth of around 14-15 per cent, with earnings before interest, taxes, depreciation, and amortisation (Ebitda) growth of 24-30 per cent for Q1 of FY24. Hospitals are, however, likely to report lower occupancy rates, and diagnostics companies may witness an impact from delayed monsoon.

Sensex ends flat in cautious trade

Sensex ends flat in cautious trade

Rediff.com20 Sep 2017

Among major gainers, ITC, Reliance Industries, Dr Reddy's and HDFC rose up to 3 per cent.

Sensex tanks 202 pts as Covid surge continued to weigh on investors sentiments

Sensex tanks 202 pts as Covid surge continued to weigh on investors sentiments

Rediff.com23 Apr 2021

M&M was the top loser in the Sensex pack, shedding over 2 per cent, followed by Dr Reddy's Bharti Airtel, Tech Mahindra, HUL, ICICI Bank and Infosys. NSE Nifty dropped 64.80 points to 14,341.35.

Sensex pares losses; finally ends down 581 pts on weak global cue

Sensex pares losses; finally ends down 581 pts on weak global cue

Rediff.com27 Jan 2022

HCL Tech was the top loser in the Sensex pack, skidding over 4 per cent, followed by Tech Mahindra Dr Reddy's, Wipro, TCS, Titan and Infosys. NSE Nifty plunged 167.80 points to 17,110.15.

Markets spurt over 1%; Sensex gains 712 points

Markets spurt over 1%; Sensex gains 712 points

Rediff.com29 Jul 2022

Benchmark indices continued to rally for the third day running on Friday with the Sensex climbing 619 points in early trade to reclaim the 57,000 level. The 30-share BSE benchmark jumped 619.27 points to 57,477.06. The broader NSE Nifty advanced 189.15 points to 17,118.75.

Prominent Desis hail Trump's re-election

Prominent Desis hail Trump's re-election

Rediff.com7 Nov 2024

Eminent Indian Americans on Wednesday welcomed the re-election of Donald Trump as the 47th president of the United States and assured to work with him on several issues, including that of the United States-India relationship.

Sensex, Nifty drop nearly 1% on global recession fears

Sensex, Nifty drop nearly 1% on global recession fears

Rediff.com26 Jul 2022

Benchmark BSE Sensex and Nifty closed lower by nearly 1 per cent on Tuesday amid fresh foreign fund outflows and mixed global trends. The 30-share BSE benchmark fell by 497.73 points or 0.89 per cent to settle at 55,268.49, extending its losses for second straight day. During the day, it tanked 562.79 points or 1 per cent to 55,203.43. The broader NSE Nifty declined by 147.15 points or 0.88 per cent to 16,483.85.

DRL to showcase new findings in US

DRL to showcase new findings in US

Rediff.com14 Jun 2003

Sensex sinks 486 pts led by losses in index majors

Sensex sinks 486 pts led by losses in index majors

Rediff.com8 Jul 2021

Tata Steel was the top loser in the Sensex pack, shedding over 2 per cent, followed by Sun Pharma, ICICI Bank, SBI, Kotak Bank and Dr Reddy's. NSE Nifty dropped 151.75 points to 15,727.90.

Pharma sector seeks boost to research, innovation

Pharma sector seeks boost to research, innovation

Rediff.com3 Jul 2014

Pharma firms wants new policies that will boost investment.

Pharma sector seeks boost to research, innovation

Pharma sector seeks boost to research, innovation

Rediff.com3 Jul 2014

Pharma firms wants new policies that will boost investment.

RIL, ITC, Kotak Bank drag Sensex down by 166 points

RIL, ITC, Kotak Bank drag Sensex down by 166 points

Rediff.com14 Dec 2021

ITC was the top loser in the Sensex pack, shedding nearly 3 per cent, followed by Bajaj Finance, Kotak Bank, Bharti Airtel and Reliance Industries. Nifty fell 43.35 points to 17,324.90.

Sensex, Nifty rebound sharply after 4-day rout

Sensex, Nifty rebound sharply after 4-day rout

Rediff.com8 Mar 2022

From the 30-share pack, Sun Pharma, TCS, Tech Mahindra, NTPC, Wipro, UltraTech Cement, Dr Reddy's Laboratories and Infosys were the major gainers, jumping up to 3.99 per cent. In contrast, Tata Steel, Nestle, Titan Company, PowerGrid, Reliance Industries Limited and State Bank of India were among the laggards.

Drugs of 7 Indian pharma firms in EMA's suspension list

Drugs of 7 Indian pharma firms in EMA's suspension list

Rediff.com4 Feb 2015

Indian pharma firms under European drug regulator's scanner.

Investors' wealth rises Rs 5.66 lakh crore as equity markets rebound

Investors' wealth rises Rs 5.66 lakh crore as equity markets rebound

Rediff.com4 Oct 2022

Equity investors became richer by Rs 5.66 lakh crore as markets bounced back sharply on Tuesday following a recovery in global equities. The 30-share BSE Sensex jumped 1,276.66 points or 2.25 per cent to settle at 58,065.47 points. During the day, it zoomed 1,311.13 points or 2.30 per cent to 58,099.94 points. The market capitalisation of BSE-listed firms climbed Rs 566,318.84 crore to Rs 273,92,739.78 crore.

Meet The Real Star Of Paatal Lok

Meet The Real Star Of Paatal Lok

Rediff.com27 Feb 2025

'Sudip sir keeps telling me that what I have done is very Hollywood.'

Denied bypoll ticket, Karnataka BJP leader joins Cong

Denied bypoll ticket, Karnataka BJP leader joins Cong

Rediff.com23 Oct 2024

In a dramatic development, Bharatiya Janata Party leader and former Minister C P Yogeeshwara on Wednesday quit his party and joined the Congress, which is now expected to field him in the November 13 assembly bypolls from Channapatna.

'Judgment Is A Constitutional Earthquake'

'Judgment Is A Constitutional Earthquake'

Rediff.com21 Nov 2024

'It has changed the political character of India by ejecting socialism as an ideology from the Constitution of India.'

4 ADRs at an all time high

4 ADRs at an all time high

Rediff.com31 Dec 2003

Electoral bonds: Congress flags mismatch in donor, recipient files

Electoral bonds: Congress flags mismatch in donor, recipient files

Rediff.com15 Mar 2024

It also asked why the data shared pertained to a period from April 2019 even though the scheme for anonymous political funding was introduced in 2017.

Sensex pares early gains as IT stocks crack

Sensex pares early gains as IT stocks crack

Rediff.com9 Dec 2022

Equity benchmark Sensex declined nearly 390 points on Friday, pressured by heavy selling in IT, tech and energy stocks despite a positive trend in the global markets. Besides, rising crude oil prices and relentless foreign capital outflows further weighed on sentiment, traders said. The 30-share BSE Sensex opened strong but came under severe selling pressure to close 389.01 points or 0.62 per cent lower at 62,181.67.

Jayalalithaa's death: TN panel indicts Sasikala, govt prepares for action

Jayalalithaa's death: TN panel indicts Sasikala, govt prepares for action

Rediff.com18 Oct 2022

The Justice A Arumughaswamy Commission of Inquiry that probed the circumstances leading to Jayalalithaa's death in 2016, in its concluding remarks said that V K Sasikala, the late Chief Minister's confidante, 'have to be found fault with and investigation is to be ordered'.

Who Won By The Highest/Lowest Margins?

Who Won By The Highest/Lowest Margins?

Rediff.com5 Jun 2024

Hemant V Shivsaran/Rediff.com does a deep dive and lists the winners with the highest and lowest margins in the recent Lok Sabha elections.

Sensex gains 345 points at close; FMCG, auto shares shine

Sensex gains 345 points at close; FMCG, auto shares shine

Rediff.com15 Jul 2022

Benchmark BSE Sensex rebounded by 344 points while Nifty closed above the 16,000 level in choppy trade on Friday, snapping the four-day falling streak on renewed buying interest from foreign funds and firm global trends. The 30-share BSE barometer climbed 344.63 points or 0.65 per cent to settle at 53,760.78. During the day, it jumped 395.22 points or 0.73 per cent to 53,811.37.

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

Rediff.com11 Apr 2021

These vaccines are Sputnik V vaccine (in collaboration with Dr Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.

Domestic pharma market grew by 6.8% in 2023

Domestic pharma market grew by 6.8% in 2023

Rediff.com22 Jan 2024

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. This indicates the price increase has been the major growth driver. Growth in the moving annual turnover (the previous 12 months' turnover) in December was 5.1 per cent and that in new product introduction 2.6 per cent, while volumes dipped 0.9 per cent, leading to an overall growth rate of 6.8 per cent, according to the data from market research firm Pharmatrac.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

What The Mohan Babu-Manoj Feud Is About

What The Mohan Babu-Manoj Feud Is About

Rediff.com11 Dec 2024

All is not well between veteran Telugu actor Mohan Babu and his son Manchu Manoj.

TCS, Infosys in Forbes 'Super 50' list

TCS, Infosys in Forbes 'Super 50' list

Rediff.com26 Jul 2016

Companies which have been dropped from the list include Tata Motors, Hindustan Unilever, MRF, Glaxo SmithKline Consumer Healthcare, Pfizer, Dr Reddy's Labs, Glenmark Pharmaceuticals, HDFC and Kotak Mahindra Bank

Markets settle marginally higher on fag-end buying

Markets settle marginally higher on fag-end buying

Rediff.com18 Aug 2022

Equity benchmark Sensex gained 37 points on Thursday, tracking gains in index majors Kotak Bank, L&T and Bharti Airtel amid a largely negative trend in global markets. After a largely choppy session, the 30-share BSE index ended 37.87 points or 0.06 per cent higher at 60,298 after starting the trade on a weak note. During the day, it hit a high of 60,341.41 and a low of 59,946.44.

4 reports that expose Reddys' misdeeds in Bellary

4 reports that expose Reddys' misdeeds in Bellary

Rediff.com5 Sep 2011

With the arrest of Bellary mining magnate Janardhan Reddy by the Central Bureau of Investigation, the focus has now shifted to the Obulapuram Mining Company, the lease for which was granted by the Andhra Pradesh government then led by Dr Y S Rajasekhara Reddy.

When bears came calling, Sensex tanked 1,145 points

When bears came calling, Sensex tanked 1,145 points

Rediff.com22 Feb 2021

Dr Reddy's was the top loser in the Sensex pack, shedding around 5 per cent, followed by M&M, Tech Mahindra, Axis Bank, IndusInd Bank and TCS. NSE Nifty sank 306.05 points to finish at 14,675.70.

Sensex, Nifty end in red on profit booking

Sensex, Nifty end in red on profit booking

Rediff.com4 Aug 2022

Equity benchmarks snapped their six-session rally to close marginally lower on Thursday amid profit booking in banking and energy counters. Investors also stayed on the sidelines ahead of the RBI's policy meet outcome on Friday. In choppy trade, the 30-share BSE Sensex ended 51.73 points or 0.09 per cent lower at 58,298.80. During the day, it hit a low of 57,577.05 and a high of 58,712.66.

Markets rally for 2nd day; Sensex jumps 1,041 points

Markets rally for 2nd day; Sensex jumps 1,041 points

Rediff.com28 Jul 2022

Benchmark indices rallied on Thursday with the Sensex and Nifty climbing nearly 2 per cent, helped by heavy buying in Bajaj Finance shares amid a mixed trend in the global equity markets. The 30-share BSE benchmark jumped 1,041.47 points or 1.87 per cent to settle at 56,857.79. During the day, it rallied 1,097.9 points or 1.96 per cent to 56,914.22. The broader NSE Nifty advanced 287.80 points or 1.73 per cent to 16,929.60.

Bull rules D-Street; Sensex zooms 2,315 points

Bull rules D-Street; Sensex zooms 2,315 points

Rediff.com1 Feb 2021

On the Sensex chart, IndusInd Bank was the top gainer, rallying over 11 per cent, followed by ICICI Bank, SBI, HDFC, M&M and Axis Bank. On the other hand, Dr Reddy's, Tech Mahindra and TCS were among the laggards.

Realty, auto, metal stocks drag Sensex down by 550 points

Realty, auto, metal stocks drag Sensex down by 550 points

Rediff.com18 Jan 2022

Equity benchmark Sensex plunged by 554.05 points on Tuesday, tracking deep losses in realty, auto and metal stocks amid widespread selling pressure in global markets. The 30-share index slumped by 554.05 points or 0.90 per cent to end at 60,754.86. The broader NSE Nifty fell by 195.05 points or 1.07 per cent to 18,113.05.

Sensex climbs 284 points to settle at 55,682

Sensex climbs 284 points to settle at 55,682

Rediff.com21 Jul 2022

Benchmark indices bounced back after falling in early trade on Thursday and logged the fifth day of gain amid a decline in crude oil prices and foreign funds inflow. The 30-share BSE Sensex climbed 284.42 points or 0.51 per cent to settle at 55,681.95. During the day, it jumped 340.96 points or 0.61 per cent to 55,738.49. The broader NSE Nifty went higher by 84.40 points or 0.51 per cent to 16,605.25.

Sensex, Nifty advance on gains in IT, FMCG stocks

Sensex, Nifty advance on gains in IT, FMCG stocks

Rediff.com15 Nov 2021

Stock market barometers Sensex and Nifty ended marginally higher on Monday as rise in wholesale inflation capped early gains despite a positive trend in global markets. The 30-share index settled 32.02 points or 0.05 per cent higher at 60,718.71 with half of its constituents ending in green. The broad based Nifty edged up 6.70 points or 0.04 per cent to close at 18,109.45.